These published data indicate the existence of a positive relationship between GR and 11β-HSD1 in regulation of hepatic gluconeogenic enzymes, implicating GR or 11β-HSD1 as a potential target for the treatment of type 2 diabetes and obesity. This evidence concerns the gene NR3C1 and obesity disorder.